Product Images Abacavir And Lamivudine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Abacavir And Lamivudine NDC 69097-362 by Cipla Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
d306e740 28b8 4975 acd3 5261dc07ed47 01
d306e740 28b8 4975 acd3 5261dc07ed47 02
d306e740 28b8 4975 acd3 5261dc07ed47 03
This is a description for Abacavir and Lamivudine tablets, USP which come in a 600 mg/300 mg dosage. The package contains 90 tablets. The text also includes instructions for authorized dispenser related to patient information, warning signs, and dosages. The tablets have been manufactured by Cipla USA. The rest of the text is not understandable due to scanning errors and inaccuracies.*
d306e740 28b8 4975 acd3 5261dc07ed47 04
The text is a description of Abacavir and Lamivudine Tablets, USP used for the treatment of patients with HIV-1 infection. Each tablet contains Abacavir Sulfate USP equivalent to Abacavir 600 mg and Lamivudine USP 300 mg. The recommended dosage is given in the prescribing information. They are manufactured by Cipla Ltd. in India and distributed by Cipla USA, Inc. in Florida, USA. They need to be stored at a controlled room temperature between 15°C to 30°C (59°F to 86°F), and kept out of reach of children.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.